Spyre Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Spyre Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q4 2023.
  • Spyre Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$3.43M -100% Dec 31, 2023 10-K/A 2024-11-18
Q3 2023 $0 -$3.51M -100% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.32M -$1.3M -35.9% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $3.27M -$446K -12% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $3.43M -$376K -9.88% Dec 31, 2022 10-K/A 2024-11-18
Q3 2022 $3.51M -$383K -9.83% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $3.62M -$397K -9.9% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $3.71M -$411K -9.97% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $3.81M -$424K -10% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $3.9M -$497K -11.3% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $4.01M -$545K -12% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $4.12M -$589K -12.5% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $4.23M -$496K -10.5% Dec 31, 2020 10-K 2022-03-08
Q3 2020 $4.39M -$478K -9.81% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $4.56M -$461K -9.19% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $4.71M +$4.09M +659% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $4.73M Dec 31, 2019 10-K 2021-03-18
Q3 2019 $4.87M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $5.02M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $621K Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.